Related Experiment Video
Updated: Jun 24, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
Novel type of Streptococcus pneumoniae causing multidrug-resistant acute otitis media in children
Qingfu Xu1, Michael E Pichichero, Janet R Casey
1University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
Abstract:
After our recent discovery of a Streptococcus pneumoniae 19A "superbug" (Legacy strain) that is resistant to all Food and Drug Administration-approved antimicrobial drugs for treatment of acute otitis media (AOM) in children, other S. pneumoniae isolates from children with AOM were characterized by multilocus sequence typing (MLST). Among 40 isolates studied, 16 (40%) were serotype 19A, and 9 (23%) were resistant to multiple antimicrobial drugs. Two others had unreported sequence types (STs) that expressed the 19A capsule, and 8 (88%) of the 9 multidrug-resistant strains were serotype 19A, including the Legacy strain with the new ST-2722. In genetic relatedness, ST-2722 belonged to a cluster of reported strains of S. pneumoniae in which all strains had 6 of the same alleles as ST-156. The multidrug-resistant strains related to ST-156 expressed different capsular serotypes: 9V, 14, 11A, 15C, and 19F.
Insights
A Streptococcus pneumoniae "superbug" resistant to all drugs for childhood ear infections was discovered. Further analysis revealed multiple drug-resistant strains, predominantly serotype 19A, highlighting a growing public health concern.
Area of Science:
- Microbiology
- Genetics
- Public Health
Background:
- Acute otitis media (AOM) in children is frequently caused by Streptococcus pneumoniae.
- Emergence of antimicrobial resistance in S. pneumoniae poses a significant challenge to AOM treatment.
- A novel 19A S. pneumoniae strain (Legacy strain) resistant to all FDA-approved drugs for AOM was recently identified.
Purpose of the Study:
- To characterize additional S. pneumoniae isolates from children with AOM.
- To identify the prevalence of multidrug-resistant (MDR) strains and their serotypes.
- To investigate the genetic relatedness of MDR strains.
Main Methods:
- Multilocus sequence typing (MLST) was performed on 40 S. pneumoniae isolates from children with AOM.
- Serotyping was conducted to determine the capsular type of the isolates.
- Genetic relatedness analysis was used to cluster strains based on MLST data.
Main Results:
- 16% of isolates were serotype 19A, and 23% were multidrug-resistant.
- 88% of MDR strains (8 out of 9) were serotype 19A, including the Legacy strain with a new sequence type (ST-2722).
- ST-2722 is genetically related to ST-156, with MDR strains linked to ST-156 expressing various serotypes (9V, 14, 11A, 15C, 19F).
Conclusions:
- Serotype 19A is a significant cause of multidrug-resistant Streptococcus pneumoniae in children with AOM.
- The emergence of new sequence types, like ST-2722, associated with MDR strains is a concern.
- Continued surveillance and characterization of resistant S. pneumoniae strains are crucial for public health.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Atypical Pneumonia
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Streptococcal Pharyngitis
Clinical Significance of Antibiotic Resistance
